Skip to main content
KOD
NASDAQ Life Sciences

Kodiak Q3 Loss Widens to $66.2M; $69M ATM Raise Extends Runway Into 2027

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Neutral
Importance info
8
Price
$108.12
Mkt Cap
$6.795B
52W Low
$18.05
52W High
$112.31
52W Position info
499% above low
Off High info
3.7% below high
Rel. Volume info
0.2× avg
Market data snapshot near publication time

KOD has more than doubled off its 52-week low of $18.05 on light trading volume (0.2× avg).

Summary

Kodiak reported a $66.2 million Q3 net loss and $88.7 million in cash, then added $69 million in post-quarter ATM proceeds that management says funds operations into 2027. Zenkuda's BLA is planned for Q4 2026 and KSI-101 PEAK topline data are due in December 2026.


Key Events · Earnings and Guidance · KOD

  • Q3 Net Loss Widens to $66.2M

    Net loss was $66.2 million, or $1.05 per share, versus $61.5 million, or $1.16 per share, a year earlier. R&D rose to $58.3 million from $50.5 million on higher PEAK/PINNACLE and ALTO clinical activity.

  • $69M ATM Raise Extends Runway

    Kodiak raised $69 million in net proceeds from common stock sales under its ATM after September 30. With $88.7 million of cash at quarter-end, management expects funding to support operations into 2027.

  • Going-Concern Language Eased

    The release says current cash will support operations into 2027, a shift from the going-concern doubt previously disclosed in the Q2 2026 10-Q. The forward-looking statements still flag that risk.

  • Zenkuda BLA Planned for Q4 2026

    A three-indication BLA covering wet AMD, diabetic retinopathy and retinal vein occlusion is planned for the fourth quarter of 2026, backed by five positive Phase 3 studies.


Analysis · KOD · Life Sciences

This is the first hard look at Kodiak's finances since the September DAYBREAK win sent the stock from roughly $38 to above $100. The quarter itself was a cash burn story: a $66.2 million net loss and R&D up to $58.3 million as the PEAK/PINNACLE and ALTO trials scale. What changes the picture is the $69 million raised through the ATM after quarter-end, which lifts cash from $88.7 million and lets management say it expects funding into 2027 — a meaningful step back from the going-concern doubt previously disclosed in the Q2 10-Q. Against that, the equity is being sold into strength, and the next binary events are close: Zenkuda's multi-indication BLA is planned for Q4 2026 and KSI-101 PEAK topline is due in December 2026. A miss on either would hit a stock already trading near its 52-week high.

How filings like this one have moved

In the 30 days to Nov 12, 2026, 47.3% of the 1873 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.17%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, KOD was trading at $108.12 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $6.8B. The 52-week trading range was $18.05 to $112.31. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

KOD - Latest Insights

KOD
Nov 12, 2026, 4:00 PM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $108.25
Real-time Price: $109.00 info
Change: +$0.750 (+0.69%) info
Market Cap: $6.803B info
KOD
Nov 06, 2026, 4:55 PM EST
Filing Type: 4
Importance Score:
7
Price at Filing: $99.30
Real-time Price: $109.00 info
Change: +$9.70 (+10%) info
Market Cap: $6.803B info
KOD
Oct 20, 2026, 5:19 PM EDT
Filing Type: S-3ASR
Importance Score:
7
Price at Filing: $92.97
Real-time Price: $109.00 info
Change: +$16.03 (+17%) info
Market Cap: $6.803B info
KOD
Sep 30, 2026, 4:29 PM EDT
Filing Type: 4
Importance Score:
8
Price at Filing: $94.50
Real-time Price: $109.00 info
Change: +$14.50 (+15%) info
Market Cap: $6.803B info
KOD
Sep 28, 2026, 8:53 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $60.69
Real-time Price: $109.00 info
Change: +$48.31 (+80%) info
Market Cap: $6.803B info